Skip to content

Clinical trials

Macular Degeneration trials in Japan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Macular Degeneration Country / region: Japan Clear all

31 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20051
20062
20082
20091
20101
20111
20122
20133
20145
20153
20171
20202
20222
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed25
Active, not recruiting2
Unknown status2
Recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bayer7
Allergan3
Kyorin University3
Novartis Pharmaceuticals2
Pfizer2
4D Molecular Therapeutics1
AbbVie1
Alvotech Swiss AG1
Amgen1
Astellas Pharma Inc1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Macular Degeneration31
Wet Macular Degeneration4
Eye Diseases3
Retinal Degeneration2
Retinal Diseases2
Retinal Vein Occlusion2
Blindness1
Choroidal Neovascularization1
Geographic Atrophy1
Macular Edema1

Trials

Showing 76 to 31 of 31. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.